The sphingolipid ceramide [CER] has been shown to be an important mediator of signal transduction processes leading to a variety of cellular responses, including apoptosis. Despite the compelling experimental evidence to suggest that CER-dependent signaling mechanisms might underlie -cell dysfunction in in vitro and in vivo models of impaired insulin secretion, very little is known with regard to the precise modes of action of CER in the signaling events leading to metabolic dysregulation of the islet -cell. Our preliminary findings suggest that long-term exposure of INS 832/13 cells and primary rat islets to elevated glucose and lipids promote CER-dependent activation of an okadaic acid-sensitive protein phosphatase [CAPP] and the phagocytic NADPH-oxidase [NOX] leading to mitochondrial dysregulation. We also present preliminary evidence to indicate that these two pathways are accelerated in islets from the Zucker Diabetic Fatty [ZDF] rat, a widely accepted model for type 2 diabetes. Based on these data we hypothesize that an accumulation of intracellular CER, induced following chronic exposure of isolated -cells to glucose and lipids, causes mitochondrial dysfunction leading to cell demise. The three Specific Aims of the proposed studies are: [I] to demonstrate that glucolipotoxic conditions promote CER-mediated activation of the mitochondrial isoform of CAPP leading to dephosphorylation and inactivation of Bcl-2 culminating in the mitochondrial dysfunction of the islet -cell;[II] to demonstrate that glucolipotoxic conditions promote CER-mediated holoenzyme assembly and functional activation of NOX to result in the generation of ROS and the associated onset of mitochondrial dysfunction of the islet -cell;and [III] to precisely define the progression, and prevention of mitochondrial defects and metabolic dysfunction [identified under Aims I and II] by CER synthesis inhibitors in the ZDF rat islet. We will employ a number of biochemical, molecular biological, cell biological and immunological approaches to validate our hypothesis and accomplish our goals in INS 832/13 cells, primary rat islets and whole animals. It is hoped that data derived from the proposed studies will provide fresh insights into the regulatory roles of specific CER-sensitive signaling steps in the onset of mitochondrial dysfunction leading to the demise of the islet -cell under the duress of glucolipotoxic conditions. Our long-term goal is to develop specific therapeutic modalities to prevent the establishment of these cell defects and the onset of diabetes. Our proposed studies have direct relevance to the VA research and patient care missions. Available data clearly suggest that veterans are more likely than the general population to have diabetes, one of the major complications associated with obesity. According to the American Diabetes Association, greater than 7% of the U.S. population has diabetes, and the rate increases with age. Among veterans receiving VA health care, who are on average older than the general population, the rate is greater than 20%. According to the VA, 70% of the 7.5 million veterans who receive health benefits through the department are obese, and one in five has diabetes, which can lead to heart disease, high blood pressure and amputations. We envision that data derived from the proposed studies will provide fresh insights into regulatory roles of specific CER-sensitive signaling steps in the onset of mitochondrial dysfunction leading to the demise of the -cell under the duress of glucolipotoxic conditions. The data accrued from our studies might form the basis for the development of specific therapeutic modalities to prevent the establishment of these -cell defects and the onset of diabetes.
A growing body of recent evidence suggests that long-term exposure of islet -cells to elevated glucose and lipids [i.e., glucolipotoxicity] results in severe metabolic impairment and loss of functionally-active -cell mass. The precise molecular and cellular mechanisms underlying these metabolic abnormalities remain only partially understood. This proposal aims at defining novel roles for ceramide, a sphingolipid, in the development of mitochondrial defects culminating in the demise of the -cell leading to the onset of type 2 diabetes. One of the long-term goals of this project is to develop specific therapeutic modalities to prevent the establishment of these -cell defects and the onset of diabetes.
|Kowluru, Anjaneyulu (2017) Role of G-proteins in islet function in health and diabetes. Diabetes Obes Metab 19 Suppl 1:63-75|
|Kowluru, Anjaneyulu (2017) Tiam1/Vav2-Rac1 axis: A tug-of-war between islet function and dysfunction. Biochem Pharmacol 132:9-17|
|Kowluru, Renu A; Mishra, Manish; Kowluru, Anjaneyulu et al. (2016) Hyperlipidemia and the development of diabetic retinopathy: Comparison between type 1 and type 2 animal models. Metabolism 65:1570-81|
|Zhang, Xiangmin; Damacharla, Divyasri; Ma, Danjun et al. (2016) Quantitative proteomics reveals novel protein interaction partners of PP2A catalytic subunit in pancreatic ?-cells. Mol Cell Endocrinol 424:1-11|
|Fang, Jingye; Liu, Ming; Zhang, Xuebao et al. (2015) COPII-Dependent ER Export: A Critical Component of Insulin Biogenesis and ?-Cell ER Homeostasis. Mol Endocrinol 29:1156-69|
|Veluthakal, Rajakrishnan; Kumar, Binit; Mohammad, Ghulam et al. (2015) Tiam1-Rac1 Axis Promotes Activation of p38 MAP Kinase in the Development of Diabetic Retinopathy: Evidence for a Requisite Role for Protein Palmitoylation. Cell Physiol Biochem 36:208-20|
|Sidarala, Vaibhav; Veluthakal, Rajakrishnan; Syeda, Khadija et al. (2015) EHT 1864, a small molecule inhibitor of Ras-related C3 botulinum toxin substrate 1 (Rac1), attenuates glucose-stimulated insulin secretion in pancreatic ?-cells. Cell Signal 27:1159-67|
|Veluthakal, Rajakrishnan; Tunduguru, Ragadeepthi; Arora, Daleep Kumar et al. (2015) VAV2, a guanine nucleotide exchange factor for Rac1, regulates glucose-stimulated insulin secretion in pancreatic beta cells. Diabetologia 58:2573-81|
|Arora, Daleep K; Machhadieh, Baker; Matti, Andrea et al. (2014) High glucose exposure promotes activation of protein phosphatase 2A in rodent islets and INS-1 832/13 ?-cells by increasing the posttranslational carboxylmethylation of its catalytic subunit. Endocrinology 155:380-91|
|Kowluru, Anjaneyulu (2014) Deoxysphingolipids: ?-cell, beware of these new kids on the block. Diabetes 63:1191-3|
Showing the most recent 10 out of 15 publications